Diversified conglomerate Marubeni has led a $15m series B round for Enlitic, a US-based developer of medical-image management technology, that also included diagnostic image services provider Capitol Health and unnamed additional investors.
Enlitic has created a software platform that uses artificial intelligence to study x-ray images more closely, helping radiologists detect information more quickly. It will put the funding toward enhancing its artificial intelligence technology and hiring engineers and data scientists.
Marubeni will help Enlitic distribute its products in its own home country of Japan, and said in a statement: “Japan especially suffers from an aging population and a shrinking birth rate, placing an increasing burden on hospitals and radiologists.
“With Enlitic’s ground-breaking AI products, we see a way to accurately and efficiently address our current healthcare challenges in Japan and Asia, while providing superior healthcare.”
Capitol Health had previously led a $10m round for Enlitic that the latter described as a series A round, stating it had closed in 2016. The deal followed $5m of seed funding from Amplify Partners, Data Collective and various angel investors.
